Anterior subcapsular opacities and cataracts 5 years after surgery in the Visian Implantable Collamer Lens FDA trial

Journal of Refractive Surgery

Volumn 24, Issue 6, 2008, Pages 566-570

  Sanders, Donald R ^a,b  

^a Center for Clinical Research   (United States)

^b STAAR Surgical Company   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ANTERIOR SUBCAPSULAR LENS OPACITY; ARTICLE; CATARACT; CATARACT EXTRACTION; CLINICAL TRIAL; DISEASE COURSE; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; LENS; LENS IMPLANTATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MYOPIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROBABILITY; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SYMPTOM; TREATMENT OUTCOME; UNITED STATES; VISUAL ACUITY;

EID: 45249119483     PISSN: 1081597X     EISSN: None     Source Type: Journal    
DOI: 10.3928/1081597x-20080601-04     Document Type: Article

References (13)

1. Menezo JL, Peris-Martinez C, Cisneros A, Martinez-Costa R. Posterior chamber phakic intraocular lenses to correct high myopia: a comparative study between Staar and Adatomed models. J Refract Surg. 2001;17:32-42.
2. Gonvers M, Othenin-Girard P, Bornet C, Sickenberg M. Implantable contact lens for moderate to high myopia. J Cataract Refract Surg. 2001;27:380-388.
3. Arne JL, Lesueur LC. Phakic posterior chamber lenses for high myopia: functional and anatomical outcomes. J Cataract Refract Surg. 2000;26:369-374.
4. Uusitalo RJ, Aine E, Sen NH, Laatikainen L. Implantable contact lens for high myopia. J Cataract Refract Surg. 2002;28:29-36.
5. Sanders DR, Vukich JA. Incidence of lens opacities and clinically significant cataracts with the implantable contact lens: comparison of two lens designs. J Refract Surg. 2002;18:673-682.
6. Sanders DR, Doney K, Poco M; ICL in Treatment of Myopia (ICL™) Study Group. U.S. FDA Clinical trial of the implantable contact lens (ICL™) for moderate to high myopia: three-year follow-up. Ophthalmology. 2004;111:1683-1692.
7. Sanchez-Galeana CA, Smith RJ, Sanders DR, Rodriguez FX, Litwak S, Montes M, Chayet AS. Lens opacities after posterior chamber phakic intraocular lens implantation. Ophthalmology. 2003;110:781-785.
8. Sarikkola AU, Sen HN, Uusitalo RJ, Laatikainen L. Traumatic cataract and other adverse events with the implantable contact lens. J Cataract Refract Surg. 2005;31:511-524.
9. Sanders DR, Vukich JA; ICL in Treatment of Myopia (ICL™) Study Group. U.S. FDA clinical trial of the Implantable Contact Lens (ICL™) for moderate to high myopia. Ophthalmology. 2003;110:255-266.
10. Chylack LT, Wolfe JK, Singer DM, Leske C, Bullimore MA, Bailey IL, Friend J, McCarthy D, Wu SY. The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol. 1993;111:831-836.
11. SAS Institute Inc. SAS/STAT® User's Guide, Version 6. 4th ed. Vol 2. Cary, NC: SAS Institute Inc; 1989:846.
12. Gonvers M, Bornet C, Othenin-Girard P. Implantable contact lens for moderate to high myopia: relationship of vaulting to cataract formation. J Cataract Refract Surg. 2003;29:918-924.
13. Lackner B, Pieh S, Schmidinger G, Hanselmayer G, Dejaco-Ruhswurm I, Funovics M, Skorpik C. Outcome after treatment of ametropia with implantable contact lenses. Ophthalmology. 2003;110:2153-2161.